Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34750557

Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Nat Med
Publication date
2021 Nov
First author
Forde PM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Forde PM
      type
      Author
    2. name
      Anagnostou V
      type
      Author
    3. name
      Sun Z
      type
      Author
    4. name
      Dahlberg SE
      type
      Author
    5. name
      Kindler HL
      type
      Author
    6. name
      Niknafs N
      type
      Author
    7. name
      Purcell T
      type
      Author
    8. name
      Santana-Davila R
      type
      Author
    9. name
      Dudek AZ
      type
      Author
    10. name
      Borghaei H
      type
      Author
    11. name
      Lanis M
      type
      Author
    12. name
      Belcaid Z
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Forde PM
      type
      Author
    2. name
      Anagnostou V
      type
      Author
    3. name
      Sun Z
      type
      Author
    4. name
      Dahlberg SE
      type
      Author
    5. name
      Kindler HL
      type
      Author
    6. name
      Niknafs N
      type
      Author
    7. name
      Purcell T
      type
      Author
    8. name
      Santana-Davila R
      type
      Author
    9. name
      Dudek AZ
      type
      Author
    10. name
      Borghaei H
      type
      Author
    11. name
      Lanis M
      type
      Author
    12. name
      Belcaid Z
      type
      Author
    bibliography ids
    1. nci-bib-edcebeba265a0f664554134b
    book metadata
    content sha256
    23e40ce579647a9fd2e0c966f931cb39ac15ae110055a074fc78f43cb1e8c779
    document type
    citation
    dois
    1. 10.1038/s41591-021-01541-0
    electronic publication date
    display
    2021 Nov 8
    precision
    day
    year
    2021
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:34750557
    immutable id
    pubmed:34750557@23e40ce579647a9fd2e0c966f931cb39ac15ae110055a074fc78f43cb1e8c779
    journal
    abbreviation
    Nat Med
    issn electronic
    1546-170X
    issn print
    1078-8956
    issue
    11
    name
    Nature medicine
    nlm unique id
    9502015
    pages
    1910-1920
    volume
    27
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      34750557
      provenance
      batch id
      3f4d1914d2afe41e9e70
      provider
      NCBI PubMed ESummary
      record sha256
      1a06ef2494c01430186039d6fa9d5c3b683fafa7d5d80fb4fac6d2807ef285d2
      response sha256
      0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
      retrieved at
      2026-09-09T23:48:06.522634+00:00
      publication date
      display
      2021 Nov
      precision
      month
      year
      2021
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Multicenter Study
      4. Research Support, N.I.H., Extramural
      5. Research Support, Non-U.S. Gov't
      6. Research Support, U.S. Gov't, Non-P.H.S.
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/34750557/
      title
      Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial.

      Preserved source evidence · Not medical advice